Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.
about
Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancerDoes pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer?Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis, blood flow and ischemic recovery in rat critical limb ischemiaThe Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients.Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.Levels of circulating microparticles in lung cancer patients and possible prognostic value.Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment ModalitiesRole of multimodality therapy in cIIIA-N2 non-small cell lung cancer: perspective.Role of surgery in N2 NSCLC: pros.Treatment of resectable stage IIIA non-small cell lung cancer.Management of stage IIIA (N2) non-small-cell lung cancer: a transatlantic perspective†.[Postoperative survival of patients with stage IIIa non-small cell lung cancer].Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients.Neoadjuvant strategy for stage IIIA-N2 non-small cell lung cancer: chemoradiation or chemotherapy alone?Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.[Value of surgery for stage IIIa non-small cell lung cancer].Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy.
P2860
Q33908558-2CC34D37-F743-43CD-9D73-26A34463EFB6Q35039285-5CD27207-F460-40CA-A616-C5CDDE2278D6Q35204306-0C358CE0-29A7-4FE6-9A24-6F8D01CC5CFFQ35532823-1A416D47-ABA3-4887-9AB6-318C67102140Q36479805-EDFEC71E-5B67-4FA5-A61B-F75DA95E31D6Q36902597-507DB31A-324F-4CFA-9696-53E8E3B5006EQ37208677-1D25E3F4-4D5C-4C87-A6D0-915CBBD2C218Q37245399-C39A90A4-A028-4B06-AED0-B0BE02165F81Q37484854-73449730-415C-44B9-8C16-FDB892292420Q38961401-87A8A55E-8618-47AC-AA4D-6415C78EBCB7Q42322236-260CC172-CA7A-41E1-82DA-F55015D4DBBCQ42950960-C20E4CD3-A0C5-4480-ABA8-530E9D1CC16EQ43579592-2E308469-E67E-4666-9FC5-171DEA689711Q43608491-A8ED9876-3D48-40E4-959F-CA4D912F77FBQ47107096-705FAB78-E362-49C4-8BE3-8C5AE40ACD37Q51124341-C4582385-666D-4C93-80BC-6C3F78B81A68Q53077919-BDA46C1A-509F-4780-B242-CB0ACF8CE91DQ54976438-8CFB657B-07D6-4531-BDF6-231A4BCD68C2
P2860
Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Management of stage IIIA non-s ...... cic surgeons in North America.
@en
Management of stage IIIA non-s ...... cic surgeons in North America.
@nl
type
label
Management of stage IIIA non-s ...... cic surgeons in North America.
@en
Management of stage IIIA non-s ...... cic surgeons in North America.
@nl
prefLabel
Management of stage IIIA non-s ...... cic surgeons in North America.
@en
Management of stage IIIA non-s ...... cic surgeons in North America.
@nl
P2093
P1476
Management of stage IIIA non-s ...... cic surgeons in North America.
@en
P2093
Briana J K Stephenson
Felix G Fernandez
Lloyd J Edwards
Nirmal K Veeramachaneni
Richard H Feins
P304
922-6; discussion 926-8
P356
10.1016/J.ATHORACSUR.2012.04.087
P407
P577
2012-06-27T00:00:00Z